Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zarate

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Materials (Basel, Switzerland)|November 11, 2022
Thermodynamic Study of Leaching Conditions of Galena with Citrate Ions and Hydrogen Peroxide as Oxidizing AgentO J Solís-Marcial, A Nájera-Bastida, Alfonso Talavera-López, et al.
British Journal of Cancer|October 14, 2010
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patientsA Abajo, J Rodriguez, N Bitarte, et al.
Psychiatry|February 1, 1990
Evaluating the capacity to work of the mentally illH K Massel, R P Liberman, J Mintz, et al.
British Journal of Cancer|June 16, 2012
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patientsA Abajo, V Boni, I Lopez, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2011
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapyJ Rodriguez, V Boni, A Hernández, et al.
British Journal of Cancer|March 11, 2010
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysisR Zarate, J Rodríguez, E Bandres, et al.
Journal of Translational Medicine|March 22, 2017
Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumoursMiguel F Sanmamed, E Esteban, E Uriol, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Materials (Basel, Switzerland)|November 11, 2022
Thermodynamic Study of Leaching Conditions of Galena with Citrate Ions and Hydrogen Peroxide as Oxidizing AgentO J Solís-Marcial, A Nájera-Bastida, Alfonso Talavera-López, et al.
British Journal of Cancer|October 14, 2010
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patientsA Abajo, J Rodriguez, N Bitarte, et al.
Psychiatry|February 1, 1990
Evaluating the capacity to work of the mentally illH K Massel, R P Liberman, J Mintz, et al.
British Journal of Cancer|June 16, 2012
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patientsA Abajo, V Boni, I Lopez, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2011
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapyJ Rodriguez, V Boni, A Hernández, et al.
British Journal of Cancer|March 11, 2010
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysisR Zarate, J Rodríguez, E Bandres, et al.
Journal of Translational Medicine|March 22, 2017
Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumoursMiguel F Sanmamed, E Esteban, E Uriol, et al.
Pageof 3